Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tivumecirnon

Product Specifications

UNSPSC Description

Tivumecirnon (FLX475) is an orally bioactive, selective CCR4 antagonist. Tivumecirnon can block the recruitment of immunosuppressive regulatory T cells (Treg) into the tumor microenvironment, leading to enhanced antitumor activity. Tivumecirnon has antitumor activity on EBV+ NK/T cell lymphoma and non-small cell lung cancer (NSCLC) combined with Pembrolizumab (HY-P9902). Tivumecirnon is promising for research of broad range of tumor types[1][2][3][4].

Target Antigen

CCR

Type

Reference compound

Related Pathways

GPCR/G Protein;Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/tivumecirnon.html

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C[C@H](C1=C(C=C(C=C1)Cl)Cl)N2C3=NC(N4CC([C@H]5CCCN(C5)CCO)C4)=CN=C3C(C(F)(F)F)=N2

Molecular Weight

543.41

References & Citations

[1]Hilary Plake BECK, et al. Chemokine receptor modulators and uses thereof. WO2018022992.|[2]Adam Grant, et al. Abstract 2485: A combined mregDC and Treg signature associates with antitumor efficacy of CCR4 antagonist tivumecirnon FLX475. Cancer Res 15 March 2024; 84 (6_Supplement): 2485.|[3]Tae Min Kim, et al. 629-C Phase 2 safety and efficacy of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with non-small cell lung cancer not previously treated with checkpoint inhibitor[J]. 2023.|[4]Dirk G. Brockstedt, et al., Clinical and biological activity of FLX475, an oral CCR4 antagonist, in advanced cancer. Journal of Clinical Oncology. 2023. 41, 2625-2625.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-148494/Tivumecirnon-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-148494/Tivumecirnon-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

2174938-78-2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CBP Antibody (YA1314)
HY-P81569 Inquire

CBP Antibody (YA1314)

Ask
View Details
DAPK1 Antibody
A18955-100UL 100 µL

DAPK1 Antibody

Ask
View Details
Anti-IL-3R alpha/CD123 Antibody, Rabbit Polyclonal
MBS8124826-01 0.1 mL

Anti-IL-3R alpha/CD123 Antibody, Rabbit Polyclonal

Ask
View Details
Anti-IL-3R alpha/CD123 Antibody, Rabbit Polyclonal
MBS8124826-02 5x 0.1 mL

Anti-IL-3R alpha/CD123 Antibody, Rabbit Polyclonal

Ask
View Details
GPR87 (BC009540) Human Untagged Clone
SC123702 10 µg

GPR87 (BC009540) Human Untagged Clone

Ask
View Details
mAb anti-human PTP1-C
MBS592205-01 0.1 mg

mAb anti-human PTP1-C

Ask
View Details